BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18796185)

  • 1. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
    Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
    Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.
    Konradsson-Geuken A; Wu HQ; Gash CR; Alexander KS; Campbell A; Sozeri Y; Pellicciari R; Schwarcz R; Bruno JP
    Neuroscience; 2010 Sep; 169(4):1848-59. PubMed ID: 20600676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
    Linderholm KR; Skogh E; Olsson SK; Dahl ML; Holtze M; Engberg G; Samuelsson M; Erhardt S
    Schizophr Bull; 2012 May; 38(3):426-32. PubMed ID: 20729465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.
    Pershing ML; Bortz DM; Pocivavsek A; Fredericks PJ; Jørgensen CV; Vunck SA; Leuner B; Schwarcz R; Bruno JP
    Neuropharmacology; 2015 Mar; 90():33-41. PubMed ID: 25446576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow.
    Hare SM; Adhikari BM; Mo C; Chen S; Wijtenburg SA; Seneviratne C; Kane-Gerard S; Sathyasaikumar KV; Notarangelo FM; Schwarcz R; Kelly DL; Rowland LM; Buchanan RW
    Neuropsychopharmacology; 2023 Oct; 48(11):1594-1601. PubMed ID: 37118058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative kynurenic acid synthesis routes studied in the rat cerebellum.
    Blanco Ayala T; Lugo Huitrón R; Carmona Aparicio L; Ramírez Ortega D; González Esquivel D; Pedraza Chaverrí J; Pérez de la Cruz G; Ríos C; Schwarcz R; Pérez de la Cruz V
    Front Cell Neurosci; 2015; 9():178. PubMed ID: 26041992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats.
    Frescura F; Stark T; Tiziani E; Di Martino S; Ruda-Kucerova J; Drago F; Ferraro L; Micale V; Beggiato S
    Pharmacol Rep; 2024 May; ():. PubMed ID: 38789891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenic acid inflammatory signaling expands in primates and impairs prefrontal cortical cognition.
    Yang S; Datta D; Krienen FM; Ling E; Woo E; May A; Anderson GM; Galvin VC; Gonzalez-Burgos G; Lewis DA; McCarroll SA; Arnsten AF; Wang M
    bioRxiv; 2024 Jun; ():. PubMed ID: 38915595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative Pharmacology in the Treatment of Substance Use Disorders.
    Donlon J; Kumari P; Varghese SP; Bai M; Florentin OD; Frost ED; Banks J; Vadlapatla N; Kam O; Shad MU; Rahman S; Abulseoud OA; Stone TW; Koola MM
    J Dual Diagn; 2024; 20(2):132-177. PubMed ID: 38117676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prepubertal Environmental Enrichment Prevents Dopamine Dysregulation and Hippocampal Hyperactivity in MAM Schizophrenia Model Rats.
    Zhu X; Grace AA
    Biol Psychiatry; 2021 Feb; 89(3):298-307. PubMed ID: 33357630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tryptophan Metabolite Indole-3-Propionic Acid Raises Kynurenic Acid Levels in the Rat Brain In Vivo.
    Sathyasaikumar KV; Blanco-Ayala T; Zheng Y; Schwieler L; Erhardt S; Tufvesson-Alm M; Poeggeler B; Schwarcz R
    Int J Tryptophan Res; 2024; 17():11786469241262876. PubMed ID: 38911967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection effects of kynurenic acid-loaded micelles for the Parkinson's disease models.
    Chen CM; Huang CY; Lai CH; Chen YC; Hwang YT; Lin CY
    J Liposome Res; 2024 May; ():1-12. PubMed ID: 38779944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives.
    Fejes A; Párdutz A; Toldi J; Vécsei L
    Curr Neuropharmacol; 2011 Jun; 9(2):376-87. PubMed ID: 22131946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia.
    Kesby JP; Cui X; Burne TH; Eyles DW
    Front Cell Neurosci; 2013; 7():111. PubMed ID: 23882183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenalectomy exacerbates stress-induced impairment in fear discrimination: A causal role for kynurenic acid?
    Klausing AD; Fukuwatari T; DeAngeli N; Bucci DJ; Schwarcz R
    Biochem Pharmacol; 2024 Jun; ():116350. PubMed ID: 38852644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats.
    Dias BB; Carreño F; Helfer VE; Olivo LB; Staudt KJ; Paese K; Barreto F; Meyer FS; Herrmann AP; Guterres SS; Rates SMK; de Araújo BV; Trocóniz IF; Dalla Costa T
    CPT Pharmacometrics Syst Pharmacol; 2024 Apr; 13(4):638-648. PubMed ID: 38282365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthurenic acid: A role in brain intercellular signaling.
    Maitre M; Taleb O; Jeltsch-David H; Klein C; Mensah-Nyagan AG
    J Neurochem; 2024 Mar; ():. PubMed ID: 38481090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum.
    Okuno A; Fukuwatari T; Shibata K
    J Neurochem; 2011 Sep; 118(5):796-805. PubMed ID: 21711351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
    Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
    Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
    Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
    Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.